Healthcare provider profile · identity verified

Alexandra J Cloukey, FNPC

Nurse Practitioner · LEE, ME · NPI 1215595749

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	351	97
Atorvastatin Calcium	Atorvastatin Calcium	301	86
Amlodipine Besylate	Amlodipine Besylate	270	80
Losartan Potassium	Losartan Potassium	268	75
Levothyroxine Sodium	Levothyroxine Sodium	220	53
Omeprazole	Omeprazole	198	59
Hydrochlorothiazide	Hydrochlorothiazide	197	58
Pantoprazole Sodium	Pantoprazole Sodium	180	46
Metoprolol Succinate	Metoprolol Succinate	169	42
Furosemide	Furosemide	161	42
Pregabalin	Pregabalin	146	29
Metoprolol Tartrate	Metoprolol Tartrate	113	29
Jardiance	Empagliflozin	112	26
Lovastatin	Lovastatin	108	30
Trazodone Hcl	Trazodone Hcl	100	29
Albuterol Sulfate Hfa	Albuterol Sulfate	98	37
Potassium Chloride	Potassium Chloride	95	26
Carvedilol	Carvedilol	92	26
Tamsulosin Hcl	Tamsulosin Hcl	91	30
Rosuvastatin Calcium	Rosuvastatin Calcium	84	25
Famotidine	Famotidine	81	22
Eliquis	Apixaban	79	25
Glipizide	Glipizide	79	24
Metformin Hcl Er	Metformin Hcl	78	26
Ozempic	Semaglutide	77	15
Metformin Hcl	Metformin Hcl	76	25
Trulicity	Dulaglutide	75	12
Montelukast Sodium	Montelukast Sodium	74	19
Simvastatin	Simvastatin	70	23
Allopurinol	Allopurinol	69	15
Gabapentin	Gabapentin	69	18
Meloxicam	Meloxicam	67	18
Tramadol Hcl	Tramadol Hcl	66	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	65	21
Paroxetine Hcl	Paroxetine Hcl	64	15
Clopidogrel	Clopidogrel Bisulfate	63	20
Prednisone	Prednisone	61	34
Sertraline Hcl	Sertraline Hcl	58	16
Citalopram Hbr	Citalopram Hydrobromide	57	13
Ropinirole Hcl	Ropinirole Hcl	57	13
Buspirone Hcl	Buspirone Hcl	52	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	25
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	47	suppressed
Olanzapine	Olanzapine	45	suppressed
Mounjaro	Tirzepatide	44	suppressed
Alendronate Sodium	Alendronate Sodium	41	suppressed
Spironolactone	Spironolactone	40	13
Escitalopram Oxalate	Escitalopram Oxalate	36	11
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	36	suppressed
Atenolol	Atenolol	35	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	15
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Clonazepam	Clonazepam	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	14
Fenofibrate	Fenofibrate Nanocrystallized	29	12
Carbamazepine	Carbamazepine	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	13
Chlorthalidone	Chlorthalidone	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Topiramate	Topiramate	25	suppressed
Finasteride	Finasteride	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Nitroglycerin	Nitroglycerin	24	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Erythromycin	Erythromycin Base	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	14
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Baclofen	Baclofen	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Triazolam	Triazolam	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error